Title A Randomized, Multi-Center, Double Blind Phase II Study of Fruquintinib in Patients with Advanced Non-Small Cell Lung Cancer
Authors Lu, Shun
Chang, Jianhua
Liu, Xiaoqing
Shi, Jianhua
Lu, You
Li, Wei
Yang, Jinji
Zhou, Jianying
Wang, Jie
Yang, Lei
Chen, Zhiwei
Zhou, Xiangdong
Liu, Zhe
Hua, Ye
Su, Weiguo
Affiliation Shanghai Jiao Tong Univ, Shanghai Lung Canc Ctr, Shanghai Chest Hosp, Shanghai, Peoples R China.
Fudan Univ, Dept Med Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China.
Acad Mil Med Sci, Dept Pulm Oncol, Hosp 307, Canc Ctr, Beijing, Peoples R China.
Linyi Tumor Hosp, Chest Onocol Dept 2, Linyi, Peoples R China.
West China Hosp, Chest Canc Dept, Canc Ctr, Chengdu, Sichuan, Peoples R China.
Jilin Univ, Canc Ctr, Hosp 1, Changchun, Jilin, Peoples R China.
Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China.
Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China.
Zhejiang Univ, Resp Dis, Affiliated Hosp 1, Coll Med, Hangzhou, Zhejiang, Peoples R China.
Peking Univ, Deparmtne Thorac Med Oncol, Sch Oncol, Beijing Canc Hosp & Inst, Beijing, Peoples R China.
Nantong Tumor Hosp, Oncol Dept, Nangtong, Peoples R China.
Shanghai Jiao Tong Univ, Dept Shanghai Lung Canc Ctr, Shanghai Chest Hosp, Shanghai, Peoples R China.
Third Mil Med Univ, Resp Dept, Xi Nan Hosp, Chongqing, Peoples R China.
Capital Med Univ, Oncol, Beijing Chest Hosp, Beijing, Peoples R China.
Hutchison Medipharma Ltd, Shanghai, Peoples R China.
Keywords non-small cell lung cancer
PROGRESSION FREE SURVIVAL
vascular endothelial growth factor receptor
third-line treatment
Issue Date 2017
Publisher JOURNAL OF THORACIC ONCOLOGY
Citation JOURNAL OF THORACIC ONCOLOGY. 2017, 12(1), S286-S286.
URI http://hdl.handle.net/20.500.11897/501319
ISSN 1556-0864
Indexed SCI(E)
Appears in Collections: 北京肿瘤医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

百度学术™


0

Checked on Current Time




License: See PKU IR operational policies.